Expression, purification, and biochemical properties of EFA6, a Sec7 domain-containing guanine exchange factor for ADP-ribosylation factor 6 (ARF6)
Chavrier, P.; Franco, M.
Methods in Enzymology 329: 272-279
2001
ISSN/ISBN: 0076-6879 PMID: 11210544 Document Number: 540277
Document emailed within 1 workday
Related Documents
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59Hu, B.; Tian, L.; Lu, Y.; Yang, L.; Zhao, X.; Liu, J.; Wei, Y. 2003: Expression, purification and refolding of extracellular domain of mouse epidermal growth factor receptor Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20(2): 264-267
de Vries-Smits, A.M.; Pronk, G.J.; Medema, J.P.; Burgering, B.M.; Bos, J.L. 1995: Shc associates with an unphosphorylated form of the p21ras guanine nucleotide exchange factor mSOS Oncogene 10(5): 919-925
Bin, L.; Manli, C.; Jie, L.; Xiaopeng, Y.; Zhaoquan, L.; Zhongcheng, G. 2014: Expression of serum and urinary vascular endothelial growth factor-A and epidermal growth factor-like domain 7 in proliferating hemangioma treated with propranolol Hua Xi Kou Qiang Yi Xue Za Zhi 32(5): 441-445
Whitehead, I.; Kirk, H.; Kay, R. 1995: Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor Oncogene 10(4): 713-721
Byrne, J.L.; Paterson, H.F.; Marshall, C.J. 1996: p21Ras activation by the guanine nucleotide exchange factor Sos, requires the Sos/Grb2 interaction and a second ligand-dependent signal involving the Sos N-terminus Oncogene 13(10): 2055-2065
Pietrucha, T.; Stec, W.J.; Okruszek, A.; Uznański, B.; Koziołkiewicz, M.; Wilk, A.; Płucienniczak, A.; Swiatkowska, M.; Cierniewski, C.S. 1994: The epidermal growth factor-like domain from tissue plasminogen activator. Cloning in E. coli, purification and ESR studies of its interaction with human blood platelets Acta Biochimica Polonica 41(1): 25-34
Mattson, C.; Wikström, K.; Sterky, C.; Pohl, G. 1991: Synergism between tissue-type plasminogen activator and a genetically engineered variant lacking the finger domain, the growth factor domain and the first kringle domain Thrombosis and Haemostasis 65(3): 286-290
Almus, F.E.; Rao, L.V.; Rapaport, S.I. 1989: Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells Thrombosis and Haemostasis 62(4): 1067-1073
Gorina, L.G.; Pronin, A.V. 1985: Partial purification and properties of a mitogenic factor from Mycoplasma arthritidis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 10: 63-66
Waheed, A.; Shadduck, R.K. 1979: Purification and properties of L cell-derived colony-stimulating factor Journal of Laboratory and Clinical Medicine 94(1): 180-193
D'Andrea, G.; Bossone, A.; Lupone, M.Rosaria.; Peyvandi, F.; Maisto, G.; Perricone, F.; Grandone, E.; Margaglione, M. 2004: Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domain Haematologica 89(8): 979-984
Lapan, K.A.; Fay, P.J. 1998: Interaction of the A1 subunit of factor VIIIa and the serine protease domain of factor X identified by zero-length cross-linking Thrombosis and Haemostasis 80(3): 418-422
Tsai, J.J.; Cromwell, O.; Maestrelli, P.; O'Hehir, R.E.; Moqbel, R.; Kay, A.B. 1989: Leukotriene release enhancing factor. Purification, specific allergen induction, and further biologic properties Journal of Immunology 142(5): 1661-1668
Ottonello, S.; Ballabeni, A.; Soncini, C.; Dieci, G. 1994: High level expression in E. coli and purification of yeast transcription factor IIIA Biochemical and Biophysical Research Communications 203(2): 1217-1223
Ishioka, S.; Saito, T.; Hiyama, K.; Haruta, Y.; Maeda, A.; Hozawa, S.; Inamizu, T.; Yamakido, M. 1996: Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 13(2): 139-145
Wang, H.; Chen, G. 2002: Expression of vascular endothelial growth factor and its receptors, flt-1 and kinase insert domain-containing receptor in normal human endometrium during menstrual cycle Zhonghua Fu Chan Ke Za Zhi 37(12): 729-732
Velleman, S.G.; McFarland, D.C. 1999: Influence of fibroblast growth factor, insulin-like growth factor I, and transforming growth factor beta on satellite cell type i collagen expression and localization during differentiation Cytobios 100(394): 101-110
Peschen, M.; Grenz, H.; Grothe, C.; Schöpf, E.; Vanscheidt, W. 1998: Patterns of epidermal growth factor receptor, basic fibroblast growth factor and transforming growth factor-beta3 expression in skin with chronic venous insufficiency European Journal of Dermatology: Ejd 8(5): 334-338
Ihle, J.N.; Keller, J.; Oroszlan, S.; Henderson, L.E.; Copeland, T.D.; Fitch, F.; Prystowsky, M.B.; Goldwasser, E.; Schrader, J.W.; Palaszynski, E.; Dy, M.; Lebel, B. 1983: Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity Journal of Immunology 131(1): 282-287